[Insight: One of the more fascinating aspects of medical technology development is the penchant in the industry for finding different ways to accomplish traditional tasks in medical and surgical care. While certainly some technologies can be oversold for their putative clinical benefits --- driving up healthcare costs and giving the industry a bad rap --- [...]
The major national markets in Western Europe for ablation technologies account for almost 12% of the global ablation market. Their share of the total medical device market is around 30%. Healthcare spending per capita is broadly similar across all the countries for which an example forecast (France) is provided below, ranging from approximately [...]
From Report #A125, “Ablation Technologies Worldwide, 2008-2017″, published September 2008. See link.
Below are selected radiofrequency ablation products, their applications and their status of regulatory approval.
[Table=11]
For additional information on Report #A125, see link. The report may be purchased online or via Google Checkout, below.
USD3,450.00 - Worldwide Ablation Technologies, 2008-2017 (PDF) USD3,450.00 - Worldwide [...]
Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones.
At right is shown the forecast, by modality type, of ablation and other energy-based therapies through 2017. The most significant growth is expected to [...]
(See September 2008 report #A125, “Ablation Technologies Worldwide Market, 2008-2017,” from MedMarket Diligence, LLC. May be purchased online.)
Energy-based therapies generate sales of $13 billion in the United States alone, with probably another $12 billion in other developed markets worldwide. This represents around 13% of the total medical device market, and it is growing at 11% [...]
